FDA Warning Letter — Anderson Compounding Pharmacy, Inc.
The FDA took a Warning Letter action against Anderson Compounding Pharmacy, Inc. on Jan 14, 2020 (Bristol, TN). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Anderson Compounding Pharmacy, Inc.
- Date
- Jan 14, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Bristol, TN (United States)